Age and LDL Cholesterol Response to Statins
A nationwide study from Denmark shows a greater LDL cholesterol response for adults aged 75 years or older to low- to moderate-intensity statins than in
A nationwide study from Denmark shows a greater LDL cholesterol response for adults aged 75 years or older to low- to moderate-intensity statins than in
In a phase 3 trial, dupilumab therapy improved outcomes in patients with COPD who had type 2 inflammation as indicated by elevated blood eosinophil counts.
Clinical benefits were evident in patients with early symptomatic Alzheimer disease after 76 weeks of treatment with the amyloid-targeting monoclonal antibody donanemab, according to findings of
In a study that focused on Medicare coverage, insurance-related differences in treatment were found during the discharge planning process for otherwise similar patients with trauma,
In 2015–19, the use of angiotensin receptor neprilysin inhibitor (ARNI) and guideline-directed medical therapy (GDMT; renin-angiotensin blockers, beta-blockers, and mineralocorticoid receptor antagonists) was low among
While the guideline for the management of heart failure (HF) with reduced ejection fraction (HFrEF) recommends titrating the dose of beta-blockers to the maximum target
Deprescribing efforts in community-dwelling persons with dementia (PWD) should include drugs such as PPIs and NSAIDs in addition to CNS agents, investigators conclude. “Community-dwelling PWD
A study finds new use of sedatives in 1 of 15 older adults within 7 days of discharge and filling of persistent sedative prescriptions for
Use of an electronic clinical decision support system (eCDSS) to improve prescribing of medications for older adults was safe but not statistically beneficial in a study
In the ASPirin in Reducing Events in the Elderly (ASPREE) trial, older adults with gout taking allopurinol had a reduced risk of persistent physical disability,